학술논문

Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
Document Type
journal article
Source
Journal of the American Academy of Dermatology; Sep2022, Vol. 87 Issue 3, p705-709, 5p
Subject
Language
ISSN
01909622